Polyplus-transfection, siRNAsense deal

SiRNAsense received a non-exclusive, worldwide license to use Polyplus-transfection’s in vivo-jetPEI delivery technology for systemic delivery of SiRNAsense’s siRNA targeting tissue factor. The unnam...